Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of HCV Therapy on Cardiovascular Risk and Bone Health

NCT03221582 is registered in ClinicalTrials.gov with Dallas VA Medical Center as lead sponsor.

NCT NCT03221582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03221582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of HCV Therapy on Cardiovascular Risk and Bone Health
Lead sponsor
Dallas VA Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
August 28, 2017
Completion date
November 30, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, human immunodeficiency virus